Synthesis and antiprogestational properties of novel 17-fluorinated steroids

Klaus Nickisch, Hareesh B. Nair, Narkunan Kesavaram, Baishakhi Das, Robert Garfield, Shao Qing Shi, Shylesh S. Bhaskaran, Sandra L. Grimm, Dean P. Edwards

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Progesterone receptor (PR) plays a key role in reproductive functions, and compounds that inhibit progesterone action (antiprogestins) have potential use in the treatment of estrogen- and progesterone-dependent diseases, including uterine leiomyomas and breast cancer. In the present study, we chemically synthesized novel 17-fluorinated steroids and evaluated the cytotoxicity profiles of these compounds in T47D breast cancer cells compared to the activity of known antiprogestins, including ZK230 211, RU-486, CDB2914, CDB4124 and ORG33628. We analyzed in vitro receptor-binding assays and PR-transactivation assays to establish the antiprogestational activity of these molecules. The representative antiprogestin EC304 was found to inhibit in vitro tumorigenicity in a dose-dependent fashion in T47D cells by a colony formation assay at 1 and 10 nM concentrations. The potent in vivo antiprogestational activity of EC304 was also demonstrated in an antinidation assay for the interruption of early pregnancy in rats. The strong antiprogestational activity and absence of antiglucocorticoid activity in EC compounds may demonstrate their utility in the treatment of leiomyoma, endometriosis and breast cancer.

Original languageEnglish (US)
Pages (from-to)909-919
Number of pages11
Issue number9
StatePublished - 2013
Externally publishedYes


  • Antiprogestin
  • Breast cancer
  • Fluorine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology
  • Pharmacology
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'Synthesis and antiprogestational properties of novel 17-fluorinated steroids'. Together they form a unique fingerprint.

Cite this